oxazolidin-2-one has been researched along with Hematologic Malignancies in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tun, HW; Yoshimitsu, T | 1 |
Chatzi, F; Chrousos, G; Karamolegou, K; Moschovi, M; Santou, A; Tourkantoni, N; Trimis, G; Tsotra, M | 1 |
Calabuig, E; Salavert, M | 1 |
Ptushkin, VV | 1 |
4 other study(ies) available for oxazolidin-2-one and Hematologic Malignancies
Article | Year |
---|---|
Compounds, compositions, and methods of agelastatin alkaloids: patent evaluation of WO2015042239 (A1).
Topics: Alkaloids; Animals; Antineoplastic Agents; Cell Line, Tumor; Hematologic Neoplasms; Humans; Oxazolidinones; Patents as Topic; Porifera; Structure-Activity Relationship | 2017 |
Efficacy and safety of linezolid in immunocompromised children with cancer.
Topics: Acetamides; Age Factors; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Greece; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Prospective Studies; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2010 |
[Role of daptomycin in the treatment of infections in patients with hematological malignancies].
Topics: Acetamides; Anti-Bacterial Agents; Antineoplastic Agents; Daptomycin; Databases, Factual; Europe; Glycopeptides; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Kidney Diseases; Linezolid; Microbial Sensitivity Tests; Minocycline; Multicenter Studies as Topic; Neutropenia; Oxazolidinones; Registries; Retrospective Studies; Risk Factors; Tigecycline; Treatment Outcome | 2010 |
[Vancomycin resistant enterococci in etiology of neutropenic enterocolitis: prophylaxis, clinical signs and treatment].
Topics: Acetamides; Adolescent; Adult; Anti-Infective Agents; Antineoplastic Agents; Drug Resistance, Bacterial; Enterococcus; Enterocolitis; Feces; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hemorrhage; Humans; Linezolid; Middle Aged; Neutropenia; Oxazolidinones; Vancomycin | 2006 |